title: [Stereotactic radiotherapy for pelvic tumors].
abstract: Extracranial stereotactic radiotherapy is booming. The development and spread of dedicated accelerators coupled with efficient methods of repositioning can now allow treatments of mobile lesions with moderate size, with high doses per fraction. Intuitively, except for the prostate, pelvic tumours, often requiring irradiation of regional lymph node drainage, lend little to this type of treatment. However, in some difficult circumstances, such as boost or re-radiation, stereotactic irradiation condition is promising and clinical experiences have already been reported.
authors.affiliation: Département de radiothérapie, institut de cancérologie Gustave-Roussy, 114, rue Édouard-Vaillant, 94805 Villejuif cedex, France. Electronic address: renaud.mazeron@gustaveroussy.fr.
authors.forename: R
authors.initials: R
authors.lastname: Mazeron
authors.affiliation: Département universitaire de radiothérapie, centre Oscar-Lambret, 3, rue Frédéric-Combenale, BP 307, 59020 Lille cedex, France.
authors.forename: I
authors.initials: I
authors.lastname: Fumagalli
mesh_terms: D001918:Brachytherapy; D006801:Humans; D008198:Lymph Nodes / Q000528:radiation effects; D008207:Lymphatic Metastasis; D009364:Neoplasm Recurrence, Local / Q000628:therapy; D058958:Organs at Risk; D010386:Pelvic Neoplasms / Q000532:radiotherapy / Q000601:surgery*; D016634:Radiosurgery; D011879:Radiotherapy Dosage
keywords: Boost; Brachytherapy; Complément d’irradiation; Curiethérapie; Pelvic tumours; Radiothérapie en conditions stéréotaxiques; Re-irradiation; Ré-irradiation; Stereotactic radiotherapy; Tumeurs pelviennes